Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The National Natural Science Foundation of China (NSFC) plays a pivotal role in supporting basic medical research and shaping national funding priorities. As clinical and scientific demands in obstetrics and gynecology grow, particularly in areas closely tied to pharmacological interventions and maternal-fetal health, understanding funding patterns is essential for guiding research strategy and health policy. This study aimed to evaluate NSFC funding trends in obstetrics and gynecology from 2011 to 2020 and examine their alignment with research output and policy-relevant themes.

Methods: Data from 2011 to 2020 were collected from official public sources. Descriptive analyses were conducted to assess funding trends by volume, project type, institutional and regional distribution, and research focus. SCI-indexed publication data were retrieved to evaluate the consistency between funding levels and high-impact scientific productivity.

Results: NSFC funding in obstetrics and gynecology increased steadily over the decade, with a notable rise in support for early-career researchers through the Young Scientists Fund. Funding was geographically concentrated in eastern China, particularly in Beijing, Shanghai, and Guangzhou, with limited representation from central and western regions. Priority research themes included gestational diseases, reproductive health, and prenatal diagnostics. The average overlap between top-funded institutions and those with high SCI publication output was 61%, indicating only partial alignment between funding distribution and scientific productivity.

Conclusions: While NSFC funding has played a critical role in advancing obstetrics and gynecology research in China, structural challenges persist. These include limited investment in high-tier and translational projects, regional disparities, and a mismatch between funding and publication output. The evolving focus of the NSFC on innovation and long-term impact over traditional publication metrics underscores the need for strategic reforms. Enhancing interdisciplinary integration, promoting equitable resource allocation, and adopting outcome-based evaluation frameworks are essential to better support pharmacological research and policy-driven improvements in maternal and reproductive health.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12392436PMC
http://dx.doi.org/10.1080/20523211.2025.2547377DOI Listing

Publication Analysis

Top Keywords

obstetrics gynecology
20
nsfc funding
12
funding
11
national natural
8
natural science
8
science foundation
8
foundation china
8
funding patterns
8
funding trends
8
2011 2020
8

Similar Publications

Background: Telemedicine is developing rapidly, presenting new opportunities and challenges for physicians and patients. Limited research has examined physicians' behavior during the process of adopting telemedicine and related factors.

Objective: This study aimed to identify perceived barriers and enablers of physicians' adoption of telemedicine and to develop intervention strategies.

View Article and Find Full Text PDF

Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.

Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.

Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).

View Article and Find Full Text PDF

Importance: Pregnant individuals with polycystic ovary syndrome (PCOS) present with a higher risk of pregnancy complications, including gestational diabetes, preeclampsia, and preterm birth. Myo-inositol supplementation may reduce these risks.

Objective: To determine whether daily supplementation with myo-inositol during pregnancy among individuals with PCOS reduces the risk of a composite outcome of gestational diabetes, preeclampsia, and preterm birth.

View Article and Find Full Text PDF

Importance: For the first time in nearly 2 decades, the US infant mortality rate has increased, coinciding with a rise in overdose-related deaths as a leading cause of pregnancy-associated mortality in some states. Prematurity and low birth weight-often linked to opioid use in pregnancy-are major contributors.

Objective: To assess the health and economic impact of perinatal opioid use disorder (OUD) treatment on maternal and postpartum health, infant health in the first year of life, and infant long-term health.

View Article and Find Full Text PDF